Oncology & Cancer

Research targets treatment resistance in neuroendocrine tumors

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for patients with advanced neuroendocrine tumors, according to new clinical trial data presented at the ...

Gastroenterology

IBS affects women more than men—here's why

For a while, the "hot girls have stomach problems" trend on social media has been a way for women to destigmatize irritable bowel syndrome (IBS).

Oncology & Cancer

Two-drug combination could improve colorectal cancer therapy

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown—only a few risk factors are known—and it is ...

page 30 from 40